This message was sent to ##Email##
Did you miss the ASHI 44th Annual Meeting in Baltimore? Purchase ASHI Access* now - recordings from the Annual Meeting - for only $75!
*Only sessions whose speakers have given permission to share their presentations will be included.
ASHI Access is a comprehensive body of knowledge readily accessible to anyone needing information from the 44th Annual Meeting.
If you have any questions, please contact Victoria Ramsay at firstname.lastname@example.org.
- Convenient and easy to access audio synchronized to PowerPoint
- Broad range of materials consistent with today's latest research
- Includes access to most of the sessions from the 44th Annual Meeting including symposia, Hot Topics, Concurrent Oral Abstracts and Workshops
Medical Professionals Laboratory Week is April 21-27, 2019.
Stay tuned for more information!
Name & Credentials: Esme Dijke, PhD
Title: Postdoctoral Fellow/ Director-in-Training
Place of employment: University of Alberta, Edmonton, Alberta, Canada
Graduated from: Erasmus University, Rotterdam, the Netherlands
How long have you been an ASHI member? 1 year
What made you decide to work in HLA? My first meeting was last year’s (2017) meeting in San Francisco, CA. The first thing that I noticed was the feeling of ‘camaraderie’ within the ASHI community. I have been to many meetings in the field of organ transplantation, but never have I felt so included right from the start as with this society. It became immediately clear that everyone is working toward common goals and collaboration is far more important than competition. I met many wonderful people and had the opportunity to interact with both peers and highly-recognized professionals. I am looking forward to attending more meetings in the future.
Click here to read more.
To be our next ASHI Member Spotlight, click here now! You can also nominate a co-worker or fellow colleague by contacting Mandi Cruz at Mcruz@ashi-hla.org.
Have you renewed your ASHI membership for 2019? If not, do it now to avoid a disruption of your ASHI benefits!
Your ASHI Membership will expire on December 31, 2018. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Click here to renew today!
If you are experiencing trouble with your ASHI website username or password, contact Membership Coordinator, Mandi Cruz at email@example.com.
The 18th IHIWS is being organized by Dr. Sebastiaan Heidt and Dr. Eric Spierings in Amsterdam, Netherlands. The meeting will be held on May 6-10, 2021 at the Westergasfabriek. The 18th IHIWS will be supported by the Dutch HLA Working Party (HLA-WN), consisting of many internationally respected professionals in the Immunogenetics and Histocompatibility field. The organizing committee has a strong commitment and aims to be very active in making sure all goals of the workshop are reached.
Click here to view the preliminary program.
The 35th EFI Conference
The 18th IHIWS will be followed by the 2021 annual EFI meeting in Amsterdam, Netherlands. This joint structure will allow for the participants of the 18th IHIWS to join the 2021 annual EFI meeting.
Follow the News
More information will soon be available via the IHIWS website.
Subscribe to the newsletter to receive regular updates on projects and progress, click here.
2018 AC-2 Survey
AC-2 results are due by 11:59pm Pacific time this coming Friday, November 30, 2018. Please check the status of your laboratory’s results to be sure the results have been submitted. Results that are saved, but not submitted, or results submitted after the deadline will not be accepted.
2018 Virtual Crossmatch Educational Challenge-2
Laboratories participating in the VXM Educational Challenge received the links necessary for participating in the challenge on November 14th. Please enter your Virtual Crossmatch results in the Google form which can be accessed using the links provided in the email.
Results for the 2018 Virtual Crossmatch Educational Challenge-2 are due the same day as the AC-2 results (11:59pm Pacific time Friday, November 30th), however, the educational virtual crossmatch survey results are to be entered, not in the Lab Center, but in the Google form created specifically for the challenge.
The 2018 HT-2 review and grading process should be completed soon. Email notifications will be sent to participating laboratories once the HT-2 report has been finalized.
The 2018 EMO-2 survey was shipped on Tuesday, November 6th. Results for EMO-2 are due by 11:59pm Pacific time Friday, December 7th. Please also check the status of your laboratory’s EMO-2 results to be sure they have been submitted.
The ASHI Technologists' Affairs committee is pleased to announce ASHI's newest Facebook groups: Technologists' Affairs Forum and Technologists’ Affairs Mentoring Forum! These forums give you a more convenient way to ask and answer specific technologist-related questions, to get or give advice and guidance on job-related challenges and to receive or offer tips on advancing within the HLA career ladder.
Both forums are private Facebook groups and are solely intended for technologist and non-doctoral members. Click the buttons below and join the discussion today!
ASHI's 2019 Regional Education Workshop
dates and locations are now available!
April 11-13, 2019
Crowne Plaza Portland Downtown Convention Center
June 27-29, 2019
The DeSoto Hotel
Stay tuned for more information.
Check out the professional photos from the 2018 ASHI Annual Meeting in Baltimore. Click here to start viewing them. Feel free to save them, share them and post them to your social media using the hashtag #ASHIAnnual2018.
Mark your calendar now for future ASHI Annual Meetings!
45TH ANNUAL MEETING
September 23-27, 2019
David L. Lawrence Convention Center
46TH ANNUAL MEETING
October 19-23, 2020
Matching of human leukocyte antigen (HLA) genes is critically important in hematopoietic stem cell transplantation (HSCT). HLA genes are highly polymorphic and HLA matching has historically been limited by technologies that are unable to unambiguously determine HLA genotypes.
Histocompatibility testing, and HLA antibody screening in particular, varies in practice among laboratories. Currently, standards are lacking regarding the reporting of testing methods in publications.
Worldwide, there is a great need of small diameter vascular grafts that can be used in human disorders such as cardiovascular and peripheral vascular disease. Until now, severe adverse reactions are caused from the use of synthetic or animal derived grafts, while the use of autologous vessels is restricted only in a small number of patients.
Donor-specific HLA antibodies (DSA) are associated with increased rates of rejection and of graft failure in cardiac transplantation. The goal of this study was to determine the association of preformed and posttransplant development of newly detected DSA (ndDSA) with antibody-mediated rejection (AMR) and characterize the clinical relevance of complement-activating DSA in heart allograft recipients.
*As recommended by the Science & Technology Initiatives Committee
Luminex single antigen bead assays revolutionized human leukocyte antigen (HLA) antibody detection owing to their superior sensitivity compared to conventional methods. Nevertheless, the advent of higher sensitivity came at the expense of difficulty in clinical decision‐making, since not all luminex detectable antibodies are clinically relevant.
*As recommended by the Science & Technology Initiatives Committee
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8